Evidence map›Paper›PMID 33806238›Full record

ArticleInternational journal of molecular sciences2021

Dynamics of Cyclooxygenase-1 Positive Microglia/Macrophage in the Retina of Pathological Model Mice as a Biomarker of the Retinal Inflammatory Diseases.

Kenichi Makabe, Sunao Sugita, Yoko Futatsugi, Masayo Takahashi

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kenichi MakabeCenter for Biosystems Dynamics Research, Laboratory for Retinal Regeneration, RIKEN, 2-2-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan.ORCID 0000-0001-5514-3824
Sunao SugitaCenter for Biosystems Dynamics Research, Laboratory for Retinal Regeneration, RIKEN, 2-2-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan.
Yoko FutatsugiCenter for Biosystems Dynamics Research, Laboratory for Retinal Regeneration, RIKEN, 2-2-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan.
Masayo TakahashiCenter for Biosystems Dynamics Research, Laboratory for Retinal Regeneration, RIKEN, 2-2-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan.
RIKEN Center for Biosystems Dynamics Research · JPKobe Kaisei Hospital · JP

Funding

KAKENHI B, 18H02959
6 · The paper itself

Abstract

In an intraocular inflammatory state, microglia residing in the retina become active and migrate inside the retina. In this study, we investigated whether cyclooxygenase-1 (COX-1) expressed by retinal microglia/macrophage can be a biomarker for the diagnosis of retinal diseases. COX-1 was immunopositive in microglia/macrophage and neutrophils, while COX-2 was immunopositive in astrocytes and neurons in the inner layer of normal retina. The number of COX-1 positive cells per section of the retinal tissue was 14 ± 2.8 (mean ± standard deviation) in normal mice, which showed significant increase in the lipopolysaccharide (LPS)-administrated model (62 ± 5.0,

Indexed as

AnimalsAstrocytesBiomarkersCyclooxygenase 1FemaleInflammationLipopolysaccharidesMacrophagesMembrane ProteinsMiceMice, Inbred C57BLMice, Inbred ICRMicrogliaNeuronsNeutrophilsRetinal DiseasesBiomarkersCyclooxygenase 1LipopolysaccharidesMembrane ProteinsPtgs1 protein, mousebiomarkercyclooxygenase-1 (COX-1)functional imagingmicrogliaretinal inflammation

Identifiers

PMID33806238
PMCPMC8036698
OpenAlexW3139519020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.